024 Pain Management System Celebrates New Arthritis Research
An Experimental Treatment in Australia Shows Promise of a New Way for Medical Practitioners to Fight Against Chronic Inflammatory Diseases; 024 Pain Management System, Specializing in a Ground-Breaking Treatment for These Conditions, Is Encouraged by the New Research
(firmenpresse) - NEW YORK, NY -- (Marketwire) -- 08/13/12 -- Patients with chronic inflammatory diseases, such as arthritis, are no stranger to pain. Although arthritis affects millions of Americans, especially those in older demographics, researchers have not yet found a cure for this elusive condition. In order to battle the severe pain associated with the disease, arthritic patients have subjected themselves to a variety of treatments and are noted to experience a decreased quality of life. On top of those difficulties, patients are reported to spend a great amount of their income on available treatments and medications. The is a revolutionary product that is designed to help lessen, and even eliminate, arthritic symptoms.
While 024 Pain Management System strives to improve the lives of arthritic patients, a recent from Medical Xpress highlights another new treatment that could possibly change the way patients approach chronic inflammatory disease. Researchers at Australia's University of Queensland's Institute for Molecular Bioscience have developed a treatment that has "proven effective at reducing symptoms and stopping the progression of the disease in models of arthritis."
Leader of the study David Fairlie explains that the experimental compound works to block the stimulation of tissue-damaging enzymes and thus, successfully reduce chronic inflammatory arthritis. In a normal immune system, these enzymes -- also known as "proteases" -- are prompted by the body to secrete healing immune cells; in patients with a chronic inflammatory disease the cells continue to release which causes ongoing pain, inflammation and tissue damage.
The article notes that the treatment is still in its initial phases, and is awaiting approval to test on human subjects. 024 Pain Management explains that, as with most medical advancements, these testing processes can require lengthy periods of observation and regulatory investigation. However, the company supports the research and notes in a recent press statement, "Finding a lasting cure for chronic pain should be the ultimate goal. We are excited about these new findings." For those that are looking for a quicker solution, the 024 Pain Management System is known to provide relief through its innovative ointment formula and is currently available for purchase.
ABOUT:
The is one of the best pain management products available in America. This system was originally created to improve the quality of life for those who live with chronic illnesses and debilitating pain. Specifically, the system is designed to help men, women and children around the world who suffer from Arthritis, Osteoarthritis, Rheumatoid Arthritis, Fibromyalgia and Diabetic Neuropathy. Satisfied users note that the all-natural topical ointment is fast and effective at reducing and eliminating pain. Additionally, the system is the only all-natural, FDA approved and patented solution that is approved by the National Fibromyalgia Association.
To learn more about the available products and how they work, visit .
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 13.08.2012 - 10:00 Uhr
Sprache: Deutsch
News-ID 173799
Anzahl Zeichen: 0
contact information:
Town:
NEW YORK, NY
Kategorie:
Personal Care & Fitness
Diese Pressemitteilung wurde bisher 205 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"024 Pain Management System Celebrates New Arthritis Research"
steht unter der journalistisch-redaktionellen Verantwortung von
024 Pain Management System (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
